Freeline Therapeutics Holdings PLC (FRLN) has gained Wednesday morning, with the stock climbing 9.03% in pre-market trading to 4.71. FRLN's short-term technical score of 35 indicates that the stock has traded less bullishly over the last month than 65% of stocks on the market. In the Biotechnology industry, which ranks 135 out of 146 industries, FRLN ranks higher than 57% of stocks. Freeline Therapeutics Holdings PLC has risen 15.20% over the past month, closing at $3.85 on September 20. During this period of time, the stock fell as low as $2.85 and as high as $5.30. FRLN has an average analyst recommendation of Strong Buy. The company has an average price target of $9.00.
FRLN has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on FRLN!